UNICA IRIS Institutional Research Information System

LACHOWICZ, JOANNA IZABELA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 153.578
NA - Nord America 7.967
AS - Asia 3.579
SA - Sud America 572
AF - Africa 102
OC - Oceania 15
Continente sconosciuto - Info sul continente non disponibili 4
Totale 165.817
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 150.639
US - Stati Uniti d'America 7.805
SG - Singapore 1.348
CN - Cina 1.165
NL - Olanda 1.085
SE - Svezia 551
BR - Brasile 439
UA - Ucraina 359
VN - Vietnam 307
FI - Finlandia 199
DE - Germania 194
GB - Regno Unito 190
FR - Francia 152
IN - India 107
HK - Hong Kong 102
CA - Canada 96
KR - Corea 78
SA - Arabia Saudita 70
BD - Bangladesh 64
AR - Argentina 43
IQ - Iraq 42
MX - Messico 42
TR - Turchia 42
JP - Giappone 39
ES - Italia 37
PK - Pakistan 35
RU - Federazione Russa 27
IR - Iran 25
ID - Indonesia 24
EC - Ecuador 22
AT - Austria 21
PL - Polonia 21
ZA - Sudafrica 21
EG - Egitto 18
IE - Irlanda 18
MA - Marocco 18
CO - Colombia 17
UZ - Uzbekistan 17
BE - Belgio 16
VE - Venezuela 15
AU - Australia 14
RO - Romania 13
TH - Thailandia 13
AE - Emirati Arabi Uniti 11
CL - Cile 11
KE - Kenya 11
TN - Tunisia 11
IL - Israele 10
MY - Malesia 10
GR - Grecia 9
JO - Giordania 9
LT - Lituania 9
PH - Filippine 9
CH - Svizzera 8
BO - Bolivia 7
PY - Paraguay 6
TW - Taiwan 6
UY - Uruguay 6
CI - Costa d'Avorio 5
CR - Costa Rica 5
CZ - Repubblica Ceca 5
NP - Nepal 5
PA - Panama 5
PE - Perù 5
PS - Palestinian Territory 5
AZ - Azerbaigian 4
BY - Bielorussia 4
DK - Danimarca 4
DZ - Algeria 4
JM - Giamaica 4
LB - Libano 4
SY - Repubblica araba siriana 4
BH - Bahrain 3
KW - Kuwait 3
QA - Qatar 3
SN - Senegal 3
AL - Albania 2
AM - Armenia 2
BG - Bulgaria 2
DO - Repubblica Dominicana 2
ET - Etiopia 2
EU - Europa 2
HU - Ungheria 2
MD - Moldavia 2
MN - Mongolia 2
NG - Nigeria 2
OM - Oman 2
PT - Portogallo 2
RS - Serbia 2
TT - Trinidad e Tobago 2
XK - ???statistics.table.value.countryCode.XK??? 2
BB - Barbados 1
BJ - Benin 1
BN - Brunei Darussalam 1
BW - Botswana 1
CD - Congo 1
DM - Dominica 1
EE - Estonia 1
GA - Gabon 1
GD - Grenada 1
Totale 165.797
Salva come PNG Salva come JPEG
Città #
Cagliari 147.613
Uta 2.475
Amsterdam 1.064
Ashburn 1.029
Fairfield 709
Singapore 664
Woodbridge 489
Dallas 449
San Jose 442
Nyköping 367
Chandler 334
Houston 316
Boardman 313
Wilmington 270
Seattle 267
Ann Arbor 254
Cambridge 230
Beijing 214
Jacksonville 181
Dearborn 164
Los Angeles 153
Helsinki 136
Santa Clara 132
Council Bluffs 124
New York 118
The Dalles 116
Ho Chi Minh City 106
Lauterbourg 91
Hong Kong 89
Boston 78
Shanghai 76
Nanjing 70
Hefei 69
Seoul 66
Hanoi 65
Dong Ket 60
Escalaplano 58
San Diego 54
Buffalo 50
Orem 50
Redwood City 48
Guangzhou 41
Chicago 39
London 39
Milan 36
Sassari 34
São Paulo 34
Hangzhou 32
Nanchang 30
Frankfurt am Main 29
Rome 29
Tianjin 27
Mountain View 25
Tokyo 25
Toronto 24
Brooklyn 23
Nuremberg 23
Redondo Beach 23
Shenyang 23
Atlanta 22
Chennai 22
Phoenix 21
Montreal 20
Munich 19
Changsha 18
Baghdad 17
Mumbai 17
Da Nang 16
Ottawa 16
Hebei 15
Jiaxing 14
Manchester 14
Norwalk 14
Pune 14
Rio de Janeiro 14
Tashkent 14
Washington 14
Brasília 13
Brussels 13
Dhaka 13
Shenzhen 13
Warsaw 13
Dublin 12
Jinan 12
Orange 12
Turku 12
Vienna 12
Zhengzhou 12
Mexico City 11
Nairobi 11
Stockholm 10
Belo Horizonte 9
Johannesburg 9
Salt Lake City 9
San Francisco 9
Amman 8
Falls Church 8
Jeddah 8
Moscow 8
New Delhi 8
Totale 160.735
Salva come PNG Salva come JPEG
Nome #
Iron Chelation for Iron Overload in Thalassemia 5.751
A new bis-3-hydroxy-4-pyrone as a potential therapeutic iron chelating agent. Effect of connecting and side chains on the complex structures and metal ion selectivity 3.854
Hydroxypyridinones with enhanced iron chelating properties. Synthesis, characterization and in vivo tests of 5-hydroxy-2-(hydroxymethyl)pyridine-4(1H)-one 3.632
Complex formation equilibria of Cu2 + and Zn2 + with Irbesartan and Losartan 3.552
para-Aminosalicylic acid in the treatment of manganese toxicity. Complexation of Mn2+ with 4-amino-2-hydroxybenzoic acid and its N-acetylated metabolite 3.539
Multi analytical technique study of human bones from an archaeological discovery 3.437
Multiple Sclerosis and environmental factors. 3.299
Adsorption of Cu2+ and Zn2+ on SBA-15 mesoporous silica functionalized with triethylenetetramine chelating agent 3.261
Gold - Old drug with new potentials 3.227
Metal coordination and tyrosinase inhibition studies with Kojic-βAla-Kojic 2.940
Searching for new aluminium chelating agents: a family of hydroxypyrone ligands 2.801
Metal coordination of thymosin β4: Chemistry and possible implications 2.793
Salicylamide derivatives for iron and aluminium sequestration. From synthesis to complexation studies 2.751
Assessment, validation and application to real samples of an RP-HPLC method for the determination of Guayulins A, B, C and D in Guayule Shrub 2.658
Thymosin b4 cytoplasmic/nuclear translocation as a new marker of cellular stress. A Caco2 case study 2.618
Looking at new ligands for chelation therapy 2.562
Geoepidemiology of Multiple Sclerosis: the environmental factors. 2.487
null 2.477
Depleted uranium and human health 2.470
A new tripodal-3-hydroxy-4-pyridinone for iron and aluminium sequestration: synthesis, complexation and in vivo studies 2.444
A new tripodal kojic acid derivative for iron sequestration: Synthesis, protonation, complex formation studies with Fe3+, Al3+, Cu2+ and Zn2+, and in vivo bioassays 2.414
Kojic acid derivatives as powerful chelators for iron(III) and aluminium(III) 2.303
Metal self-assembly mimosine peptides with enhanced antimicrobial activity: towards a new generation of multitasking chelating agentsts 2.252
Iron(III) and aluminum(III) complexes with hydroxypyrone ligands aimed to design kojic acid derivatives with new perspectives 2.231
Do anti-diabetic drugs act as copper ligands? 2.213
New insights into the protogenic and spectroscopic properties of commercial tannic acid: the role of gallic acid impurities 2.204
Toxicity of nanoparticles: etiology and mechanisms 2.156
Equilibrium studies of new bis-hydroxypyrone derivatives with Fe3+, Al3+, Cu2+ and Zn2+ 2.075
Tungsten or wolfram: Friend or foe? 2.055
Zinc(II) and copper(II) complexes with hydroxypyrone iron chelators 2.042
Chelation therapy for metal intoxication. Comments from a thermodynamic view point 1.976
Fluoroquinolones: A micro-species equilibrium in the protonation of amphoteric compounds 1.968
The meaning of aluminium exposure on human health and aluminium-related diseases 1.928
Kill or cure: Misuse of chelation therapy for human diseases 1.927
A new hydroxypyrone powerful chelator. From synthesis to AlIII, FeIII, CuII and ZnII complex formation equilibria, and structural characterization 1.900
Substituent effects on ionization constants as a predictive tool of coordinating ability 1.895
Silver coordination compounds: A new horizon in medicine 1.876
Improving Metal Adsorption on Triethylenetetramine (TETA) Functionalized SBA-15 Mesoporous Silica Using Potentiometry, EPR and ssNMR 1.864
Alarming use of chelation therapy 1.851
Iron III and aluminium III complexes with substituted salicyl-aldehydes and salicylic acids 1.838
Oxovanadium(IV) coordination compounds with kojic acid derivatives in aqueous solution 1.831
Chemical features of in use and in progress chelators for iron overload 1.829
The Best Peptidomimetic Strategies to Undercover Antibacterial Peptides 1.826
Interaction of a chelating agent, 5-hydroxy-2-(hydroxymethyl)pyridin-4(1H)-one, with Al(III), Cu(II) and Zn(II) ions 1.824
(5-Hydroxy-4-oxo-4H-pyran-2-yl)methyl3-({[(5-hydroxy-4-oxo-4H-pyran-2-yl)methoxy] carbonyl}amino) propanoate. Synthesis and its complex formation study 1.805
Comparison of selectivity of a family of chelating agents for trivalent (Al3+, Fe3+) and bivalent (Cu2+, Zn2+) metal ions 1.799
State of art in chelating agents for the clinical treatment of metal poisoning 1.795
Noble metals in medicine: Latest advances 1.786
An NMR study on the 6,6'-(2-(diethylamino)ethylazanediyl)bis(methylene)bis(5-hydroxy-2-hydroxymethyl-4H-pyran-4-one) interaction with Al(III) and Zn(II) ions 1.783
Biomonitoring of toxic element exposure by ICP-AES and ICP-MS analysis 1.777
Hydroxypyrones, an intriguing family of chelating agents for Fe(III) and Al(III) 1.767
5-hydroxy-2-(hydroxymethyl)pyridin-4(1H)-one molecule as an intriguing tool in coordination and enzymatic studies 1.764
Unusual PLS application for Pd(ii) sensing in extremely acidic solutions 1.734
A family of hydroxypyrone ligands designed and synthesized for iron chelators 1.711
Losartan: a low water soluble oral drug with Cu(II) and Zn(II) coordination properties 1.627
Competition between Cd(II) and other divalent transition metal ions during complex formation with amino acids, peptides, and chelating agents 1.615
Synthesis and Mass Spectrometry Analysis of Mimosine-Containing Peptides 1.588
Toxicity of nanoparticles 1.386
Living with the enemy: from protein-misfolding pathologies we know, to those we want to know 1.287
Warns against unapproved ‘chelation therapy’ 1.206
null 1.188
Metal ions in the pathogenesis of Alzheimer’s disease: an open field 1.157
Zinc as a drug for Wilson’s disease, non-alcoholic liver disease and covid-19-related liver injury 1.115
Grafting of the 2,8-dithia-5-aza-2,6-pyridinophane macrocycle on SBA-15 mesoporous silica for the removal of Cu2+ and Cd2+ ions from aqueous solutions: synthesis, adsorption, and complex stability studies 1.075
Undercover Toxic Ménage à Trois of Amylin, Copper (II) and Metformin in Human Embryonic Kidney Cells 975
null 941
Nutritional iron deficiency: the role of oral iron supplementation 941
Complex formation equilibria of Cu(II) and Zn(II) with triethylenetetramine and its mono- and di-acetyl metabolites 938
Thymosin β4 Is an Endogenous Iron Chelator and Molecular Switcher of Ferroptosis 926
Kojic Acid Derivatives as Iron (III) and Aluminium (III) Chelators 911
Kojic acid derivatives as double face ligands for metal and phosphate ions. 909
Different approaches to the study of chelating agents for iron and aluminium overload pathologies 904
Metal complex formation and anticancer activity of cu(I) and cu(ii) complexes with metformin 876
Exploring cell surface markers and cell-cell interactions of human breast milk stem cells 867
Study of the DNA binding mechanism and in vitro activity against cancer cells of iron(III) and aluminium(III) kojic acid derivative complexes 859
null 845
Manganese and cobalt binding in a multi-histidinic fragment 837
Metals and metal-nanoparticles in human pathologies: From exposure to therapy 817
Kojic Acid derivate as a selective inhibitor of mitosis in colorectal and glioblastoma cancer cells 815
Fluorescent squaramide ligands for cellular imaging and their encapsulation in cubosomes 739
Nickel Binding Sites in Histone Proteins: Spectroscopic and Structural Characterization 734
Generalized scleroderma-like induration associated with D-penicillamine elastosis perforans serpiginosa in Wilson's disease 719
Potentiometric, spectrophotometric and computer studies with aspergillic acid and its derivatives 704
Interaction between aspergillic acid and iron(III). A potentiometric, UV-Vis, 1H-NMR and quantum chemical study 580
Cell starvation increases uptake of extracellular Thymosin β4 and its complexes with calcium 565
Toward the renal vesicle: Ultrastructural investigation of the cap mesenchyme splitting process in the developing kidney 561
Cooking Particulate Matter: A Systematic Review on Nanoparticle Exposure in the Indoor Cooking Environment 549
Human breast milk cells are positive for the pioneer transcription factor ISL1 533
Effect of substituents on complex stability aimed at designing new iron(III) and aluminum(III) chelators 528
NMR as a “gold standard” method in drug design and discovery 503
Nuovi derivati dell’acido kojico come chelanti per il ferro(III). 481
What doesn't kill you makes you stronger: Future applications of amyloid aggregates in biomedicine 467
A pilot study of occupational exposure to ultrafine particles during 3D printing in research laboratories 446
You are what you eat: Application of Metabolomics Approaches to Advance Nutrition Research 360
Towards the functional high-resolution coordination chemistry of blood plasma human serum albumin 357
The interaction of aluminum with catecholamine-based neurotransmitters: Can the formation of these species be considered a potential risk factor for neurodegenerative diseases? 352
In silico design of mimosine containing peptides as new efficient chelators of aluminum 351
Fluxomics - New Metabolomics Approaches to Monitor Metabolic Pathways 301
Aggregation of biologically important peptides and proteins: inhibition or acceleration depending on protein and metal ion concentrations 266
Therapeutic Properties of Vanadium Complexes 231
Totale 165.484
Salva come PNG Salva come JPEG
Categoria #
all - tutte 210.117
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 210.117
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.315 0 0 0 0 0 0 0 0 0 0 0 1.315
2021/20227.745 972 731 398 535 609 618 475 271 544 755 913 924
2022/202310.333 794 1.170 1.265 886 852 1.178 597 948 686 632 785 540
2023/202411.762 588 468 435 622 1.149 1.846 1.925 1.130 521 796 1.088 1.194
2024/202524.614 5.936 6.383 3.084 2.268 1.316 1.548 1.680 155 337 1.264 312 331
2025/20267.162 498 353 799 529 438 507 1.361 648 690 805 383 151
Totale 166.238